Topical tofacitinib for the management of lymphocytic‐variant hypereosinophilic syndrome with cutaneous involvement. Issue 7 (17th May 2022) - Said, Jordan T.; Elman, Scott A.; Tawa, Marianne; Fisher, David C.; Merola, Joseph F.; Kupper, Thomas S.